NCT02441790

Brief Summary

Fractures of the fifth metacarpal neck are the most common injury involving the upper extremity. Patients are typically young adult males. Restoring function quickly and reliably for return to work and/or activity is important; these patients are a significant labour force demographic. Treatment is historically splinting for approximately 3-4 weeks. Splinting a fracture is a "trade-off". Immobilization allows stabilization and fracture healing, but also causes hand stiffness and weakness leading to impaired function. Little prospective research exists; there is no agreement for ideal duration of splinting or therapy, demonstrating clinical equipoise. A new concept in hand rehabilitation is "early active range of motion" (EAROM). The objective of this trial is to establish if EAROM provides improved early (6 week) hand function when compared to standard immobilization.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started May 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 1, 2015

Completed
Same day until next milestone

Study Start

First participant enrolled

May 1, 2015

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 12, 2015

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2017

Completed
Last Updated

December 12, 2017

Status Verified

December 1, 2017

Enrollment Period

2.1 years

First QC Date

May 1, 2015

Last Update Submit

December 11, 2017

Conditions

Keywords

5th metacarpalEAROMstandard immobilizationBoxer's Fracturehand functionDASHtrauma

Outcome Measures

Primary Outcomes (1)

  • Hand function as measured by validated scoring - the Disabilities of the Arm, Shoulder and Hand (DASH) Outcome Measure

    6 weeks

Secondary Outcomes (1)

  • HR-QOL

    3, 6 and 12 months

Study Arms (2)

Early Active Range of Motion

EXPERIMENTAL

Early Active Range of Motion (EAROM) 3-9 days following hand fracture

Behavioral: Early Active Range of Motion

Standard Immoblization

ACTIVE COMPARATOR

Standard immobilization with plaster splint for 21-27 following hand fracture

Behavioral: Standard Immobilization

Interventions

3-9 days

Early Active Range of Motion

21-27 days

Standard Immoblization

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age equal or greater than 18 years
  • Fifth metacarpal neck fracture, 9 or fewer days since injury
  • Equal or less than 40 degrees of dorsal fracture angulation on lateral x-ray. Angle is measured between the line along the longitudinal axis of the metacarpal shaft and the line from the centre of the metacarpal head to the fracture site.
  • No angulation or malrotation
  • No clinical fracture shortening (ie. Inability to extend fifth digit)
  • Non-operative treatment
  • Volar or ulnar gutter splint (MCP flexed, IPs extended)

You may not qualify if:

  • Metabolic bone disease
  • "Open fracture" with soft tissue loss overlying fracture site
  • Tendon injury
  • Neurovascular injury
  • Clinical rotatory malalignment
  • Fracture shortening demonstrated by "pseudoclawing"
  • Other fracture in the ipsilateral upper extremity
  • Any operative indication
  • Previous fracture to the involved fifth ray

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hamilton General Hospital

Hamilton, Ontario, L8L 2X2, Canada

Location

MeSH Terms

Conditions

Fractures, BoneWounds and Injuries

Study Officials

  • Michael James Cooper, MD

    McMaster University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 1, 2015

First Posted

May 12, 2015

Study Start

May 1, 2015

Primary Completion

June 1, 2017

Study Completion

June 1, 2017

Last Updated

December 12, 2017

Record last verified: 2017-12

Locations